Results 1 to 10 of about 905,283 (237)

Growth hormone response to growth hormone-releasing peptide-2 in growth hormone-deficient Little mice [PDF]

open access: yesClinics, 2012
OBJECTIVE: To investigate a possible direct, growth hormone-releasing, hormone-independent action of a growth hormone secretagogue, GHRP-2, in pituitary somatotroph cells in the presence of inactive growth hormonereleasing hormone receptors.
Cibele N. Peroni   +7 more
doaj   +4 more sources

Novel mechanisms of growth hormone regulation: growth hormone-releasing peptides and ghrelin [PDF]

open access: yesBrazilian Journal of Medical and Biological Research, 2006
Growth hormone secretion is classically modulated by two hypothalamic hormones, growth hormone-releasing hormone and somatostatin. A third pathway was proposed in the last decade, which involves the growth hormone secretagogues.
A.-M.J. Lengyel
doaj   +3 more sources

Growth Hormone-Releasing Hormone in Diabetes [PDF]

open access: yesFrontiers in Endocrinology, 2016
Growth hormone-releasing hormone (GHRH) is produced by the hypothalamus and stimulates growth hormone synthesis and release in the anterior pituitary gland.
Leonid Evsey Fridlyand   +3 more
doaj   +4 more sources

Efficacy in Japanese adults with growth hormone deficiency receiving weekly somapacitan or daily growth hormone: results from phase 3 REAL 1 trial [PDF]

open access: yesFrontiers in Endocrinology
IntroductionSomapacitan is a long-acting growth hormone (GH) derivative approved for once-weekly treatment of adult GH deficiency (AGHD). This study aimed to evaluate the efficacy and safety of somapacitan and daily GH in Japanese individuals with AGHD ...
Fumio Otsuka   +5 more
doaj   +2 more sources

On the plant growth hormone produced by Rhizopus suinus [PDF]

open access: hybrid, 1935
Since it was first discovered that cell elongation in the Avena coleoptile is controlled by a hormone, our understanding of the nature and rôle of this substance has progressed considerably. Apart from the elucidation of its functions in promoting growth,
Thimann, Kenneth V.
core   +2 more sources

Comparison of growth hormone stimulation tests in prepubertal children with short stature according to response to growth hormone replacement [PDF]

open access: yesAnnals of Pediatric Endocrinology & Metabolism
Purpose Growth hormone (GH) stimulation tests are essential tools for diagnosing GH deficiency (GHD). We aimed to compare L-dopa, insulin, and arginine-induced stimulation tests based on response to GH replacement.
Seong Hwan Chang, Chan Jong Kim
doaj   +2 more sources

Response to growth hormone according to provocation test results in idiopathic short stature and idiopathic growth hormone deficiency [PDF]

open access: yesAnnals of Pediatric Endocrinology & Metabolism, 2022
Purpose To investigate growth response in children with either idiopathic short stature (ISS) or growth hormone (GH) deficiency (GHD). Methods The data of prepubertal GHD or ISS children treated using recombinant human GH were obtained from the LG Growth
Ju Young Yoon   +9 more
doaj   +1 more source

Molecular Basis for Hypochondroplasia in Japan

open access: yesEndocrines, 2022
Hypochondroplasia is an autosomal dominant genetic disorder due to a heterozygous pathogenic variant of the FGFR3 gene. The early diagnosis of hypochondroplasia is necessary, since growth hormone is effective for improving adult height.
Tomohiro Ishii   +8 more
doaj   +1 more source

Biochemical identification of prepubertal boys with Klinefelter syndrome by combined reproductive hormone profiling using machine learning

open access: yesEndocrine Connections, 2023
Objective: Klinefelter syndrome (KS) is the most common sex chromosome disorder and genetic cause of infertility in males. A highly variable phenotype contributes to the fact that a large proportion of cases are never diagnosed.
Andre Madsen   +2 more
doaj   +1 more source

Growth hormone releasing hormone or growth hormone treatment in growth hormone insufficiency? [PDF]

open access: yesArchives of Disease in Childhood, 1988
Sixteen prepubertal children who were insufficient for growth hormone were treated with growth hormone releasing hormone (GHRH) 1-40 and GHRH 1-29 for a mean time of nine months (range 6-12 months) with each peptide. Eleven children received GHRH 1-40 in four subcutaneous nocturnal pulses (dose 4-8 micrograms/kg/day) and eight (three of whom were also ...
P J Smith, C G Brook
openaire   +3 more sources

Home - About - Disclaimer - Privacy